Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.410
-0.060 (-1.73%)
Mar 9, 2026, 2:03 PM CET

Scandinavian ChemoTech AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Operating Revenue
12.296.572.820.472.59
Upgrade
Revenue
12.296.572.820.472.59
Upgrade
Revenue Growth (YoY)
87.10%132.67%496.62%-81.70%82.82%
Upgrade
Cost of Revenue
1.991.791.160.53-0.27
Upgrade
Gross Profit
10.34.781.66-0.062.86
Upgrade
Selling, General & Admin
14.6315.4119.1217.8616.96
Upgrade
Other Operating Expenses
0.160.110.10.050.16
Upgrade
Operating Expenses
16.7617.5721.920.8619.94
Upgrade
Operating Income
-6.46-12.8-20.24-20.91-17.08
Upgrade
Interest Expense
-1.59-1.18-1.4-1.9-0.68
Upgrade
Interest & Investment Income
-0.260.550.060.01
Upgrade
Pretax Income
-8.06-13.72-21.09-22.75-17.74
Upgrade
Net Income
-8.06-13.72-21.09-22.75-17.74
Upgrade
Net Income to Common
-8.06-13.72-21.09-22.75-17.74
Upgrade
Shares Outstanding (Basic)
242113109
Upgrade
Shares Outstanding (Diluted)
242113109
Upgrade
Shares Change (YoY)
16.32%53.13%35.31%15.17%75.79%
Upgrade
EPS (Basic)
-0.34-0.66-1.56-2.28-2.05
Upgrade
EPS (Diluted)
-0.34-0.66-1.56-2.28-2.05
Upgrade
Free Cash Flow
-3.74-18.23-18.23-19.49-19.24
Upgrade
Free Cash Flow Per Share
-0.16-0.88-1.35-1.96-2.22
Upgrade
Gross Margin
83.81%72.75%58.75%-11.63%110.60%
Upgrade
Operating Margin
-52.61%-194.88%-717.12%-4421.14%-660.62%
Upgrade
Profit Margin
-65.58%-208.91%-747.38%-4808.88%-686.38%
Upgrade
Free Cash Flow Margin
-30.48%-277.58%-645.85%-4119.87%-744.18%
Upgrade
EBITDA
-4.49-12.63-20.13-20.87-17.04
Upgrade
EBITDA Margin
-36.55%-192.40%---
Upgrade
D&A For EBITDA
1.970.160.110.040.04
Upgrade
EBIT
-6.46-12.8-20.24-20.91-17.08
Upgrade
EBIT Margin
-52.61%-194.88%---
Upgrade
Revenue as Reported
12.396.772.980.512.59
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.